Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?
High body mass index (BMI) and use of hormone replacement therapy (HRT) increase the risk of postmenopausal breast cancer. It has been shown that BMI modifies the effect of HRT, as its influence is most pronounced in lean women. We investigated the influence of BMI and HRT on prognosis in 2640 postmenopausal women diagnosed with breast cancer in Sweden in 1993-1995, taking into account HRT and mammography before diagnosis. Logistic and Cox regression were used. In non-users of HRT, obese women (BMI >30) compared with normal weight women (BMI <25) had a similar prognosis (hazard ratio (HR) 1.1, 95% confidence interval (CI) 0.8-1.6), despite larger tumours found in obese women. Obese HRT users had less favourable tumour characteristics and poorer prognosis compared with normal weight women (HR 3.7, 95% CI 1.9-7.2). The influence of BMI on breast cancer prognosis was similar whether diagnosed by mammographic screening or not. We found a similar prognosis of postmenopausal breast cancer-specific death regardless of BMI in non-users of HRT, but among HRT users obesity was associated with a poorer breast cancer prognosis.
Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Box 281, SE-171 77, Stockholm, Sweden.
L
L
Rosenberg
K
K
Czene
P
P
Hall
D000368:Aged; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D016022:Case-Control Studies; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D017698:Postmenopause; D011379:Prognosis; D018570:Risk Assessment; D012907:Smoking / Q000453:epidemiology; D012959:Socioeconomic Factors; D016019:Survival Analysis; D017741:Survivors; D013548:Sweden